← Leaderboards
Katherine E Conant
Johns Hopkins University
$7,277,433
Attributed
$9,685,897
Total exposure
12
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $960.9K · FY2005–25$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,685,897 · 12
By mechanism
R01$6,794,220 · 5
R21$2,505,565 · 6
R41$386,112 · 1
Top collaborators
- Kathleen Anne Maguire-Zeiss12 shared
- Satheesh B Ravula1 shared
- John A Schetz1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ned C Sacktor$10,719,879
- Suzanne Gartner$7,702,037
- Barbara Stauch Slusher$18,499,514
- Justin Macarthur$0
- Yachi Chen$797,152
Others in their field
Top investigators on “Matrix Metalloproteinases”
- Stephen Weiss · University Of Michigan At Ann Arbor$21,235,543
- Zena Werb · University Of California San Francisco$21,125,770
- Suresh C Tyagi · University Of Louisville$17,965,642
- Gary Allen Rosenberg · University Of New Mexico$17,874,623
- Joe W. Gray · University Of California San Francisco$15,564,840
- Alex Y Strongin · Burnham Institute For Medical Research$13,840,143
Research focus
Matrix MetalloproteinasesNeuronsLinkHiv Envelope Protein Gp120BrainProteinsIn VitroAnimalsMatrix Metalloproteinase InhibitorPeptide HydrolasesImpaired CognitionStimulusMediatingCellsSlicePublishingExtracellular MatrixReceptorIn VivoAffectGlutamatesGelatinase BGamma-Aminobutyric AcidInhibitor/Antagonist
Grant awards (36)
ECM regulation and neuronal plasticity in mice harboring a common risk allele for Alzheimer's$382,200
R01 · FY2025 · AG · contact PI
ECM regulation and neuronal plasticity in mice harboring a common risk allele for Alzheimer's$390,000
R01 · FY2024 · AG · contact PI
ECM regulation and neuronal plasticity in mice harboring a common risk allele for Alzheimer's$390,000
R01 · FY2023 · AG · contact PI
ECM regulation and neuronal plasticity in mice harboring a common risk allele for Alzheimer's$390,000
R01 · FY2022 · AG · contact PI
Perineuronal proteolysis and circuit dysfunction in HAND$388,750
R01 · FY2022 · NS · contact PI
Perineuronal proteolysis and circuit dysfunction in HAND$388,750
R01 · FY2021 · NS · contact PI
Perineuronal proteolysis and circuit dysfunction in HAND$388,750
R01 · FY2020 · NS · contact PI
MMPs as mediators of anti-depressant associated hippocampal plasticity$194,375
R21 · FY2020 · MH · contact PI
Perineuronal proteolysis and circuit dysfunction in HAND$388,750
R01 · FY2019 · NS · contact PI
MMPs as mediators of anti-depressant associated hippocampal plasticity$233,250
R21 · FY2019 · MH · contact PI
Perineuronal proteolysis and circuit dysfunction in HAND$388,750
R01 · FY2018 · NS · contact PI
PAR-1 Signaling and HAND$388,750
R01 · FY2017 · NS · contact PI
PAR-1 Signaling and HAND$388,750
R01 · FY2016 · NS · contact PI
PAR-1 Signaling and HAND$388,750
R01 · FY2015 · NS · contact PI
PAR-1 Signaling and HAND$384,862
R01 · FY2014 · NS · contact PI
PAR-1 Signaling and HAND$388,750
R01 · FY2013 · NS · contact PI
Drug regulators of nitric oxide production as Alzheimer's disease therapeutics$386,112
R41 · FY2013 · AG
MMPs, Integrins and Microglial activation in HAND$186,000
R21 · FY2013 · MH · contact PI
MMPs, Integrins and Microglial activation in HAND$232,500
R21 · FY2012 · MH · contact PI
MMP-7 and SNARE Cleavage in Neuroinflammation$156,762
R21 · FY2009 · AG · contact PI
MMP-7 and SNARE Cleavage in Neuroinflammation$200,982
R21 · FY2008 · AG · contact PI
MMPs and Synaptic Injury with HIV/METH$123,804
R21 · FY2008 · DA · contact PI
MMPs and Synaptic Injury with HIV/METH$72,160
R21 · FY2008 · DA · contact PI
MMPs and Synaptic Injury with HIV/METH$246,000
R21 · FY2007 · DA · contact PI
MMPs in neural networking$184,605
R21 · FY2006 · NS · contact PI
Thrombin signaling and HIV dementia$159,658
R21 · FY2006 · MH · contact PI
MMPs in neural networking$188,469
R21 · FY2005 · NS
Thrombin signaling and HIV dementia$163,500
R21 · FY2005 · MH
Thrombin signaling and HIV dementia$163,500
R21 · FY2004 · MH
HIV 1 PROTEINS AND DRUGS OF ABUSE AND METALLOPROTEASES$225,883
R01 · FY2003 · DA
MMPS IN HIV DEMENTIA: EFFECTS ON BBB STRUCTURE/FUNCTION$136,721
R01 · FY2003 · MH
HIV 1 PROTEINS AND DRUGS OF ABUSE AND METALLOPROTEASES$227,637
R01 · FY2002 · DA
MMPS IN HIV DEMENTIA: EFFECTS ON BBB STRUCTURE/FUNCTION$137,456
R01 · FY2002 · MH
HIV 1 PROTEINS AND DRUGS OF ABUSE AND METALLOPROTEASES$229,341
R01 · FY2001 · DA
MMPS IN HIV DEMENTIA: EFFECTS ON BBB STRUCTURE/FUNCTION$154,058
R01 · FY2001 · MH
HIV 1 PROTEINS AND DRUGS OF ABUSE AND METALLOPROTEASES$247,312
R01 · FY2000 · DA